9600-034 Section 4 Test Order - Study Report

Confidential Business Information Claims under the Toxic Substances Control Act (TSCA) – Proposed Rule

8223-01_ICR_SupportingStmt_Section4TestOrderSubmission

CDX Registration

OMB: 2070-0223

Document [pdf]
Download: pdf | pdf
OMB Control No. 2070-0033
Expires 12/31/2023
CBI SUBMISSION

SECTION 4 TEST ORDER - STUDY REPORT

Submission Date: 2021-08-24

Part I - Submitter Information
Submitter
Information

Name of Authorized Official

Mailing Address

CBI

Mr William Brigman

12601 FAIRLAKES CIRCLE

X

Company Name

City, State, Zip

CGI FEDERAL

FAIRFAX, VA 22033

Phone Number

Email Address

8289191634

[email protected]

Job Title
consultant

Part II - Order Information
Order Number: TO-14321432-935362-01-A

Title of Action: test

Docket Number: EPA-HQ-OPPT-1432-1432

Part III - Chemical Information
Chemical Substance Name (Regulatory Name):
Formaldehyde

Chemical Substance
Identifier: 50-00-0
Chemical Group:

HPV Chemicals List

Chemical Category:

Chloronitrobenzenes Category

Part IV - Test Response Information
Water Solubility - OECD 105 with EPA modifications
Study Report Deadline: 09-06-2021
File Name

Document Type

Attachment Date

CBI

Attachment for Testing_1.docx

Study Report

08-24-2021

N

Part V - Technical Contact Information
Contact

Contact

Address

CBI

Mr William K Brigman

12601 FAIRLAKES CIRCLE

X

Company Name

City, State, Zip, Country

CGI FEDERAL

FAIRFAX, VA 22033, US

Telephone Number

Email Address

8289191634

[email protected]

Part VI - CBI Substantiation
File Name

CBI

Attachment for Testing_4.docx

N

Page 1

EPA Form Number 9600-034

CBI SUBMISSION

Substantiation - Applicable to Any Claim
(i) Will disclosure of the information claimed as confidential likely cause substantial harm to your business's competitive position? If
you answered yes, describe the substantial harmful effects that would likely result to your competitive position if the information is
disclosed, including but not limited to how a competitor could use such information, and the causal relationship between the
disclosure and the harmful effects.

CBI:

Yes
:No

✔

Test
(ii) Has your business taken precautions to protect the confidentiality of the disclosed information? If yes, please explain and identify
the specific measures, including but not limited to internal controls, that your business has taken to protect the information
claimed as confidential. If the same or similar information was previously reported to EPA as non-confidential (such as in an
earlier version of this submission), please explain the circumstances of that prior submission and reasons for believing the
information is nonetheless still confidential.

CBI:

Yes
:No

✔

Test
(ii) A. Is any of the information claimed as confidential required to be publicly disclosed under any other Federal law? If yes, please
explain

CBI:

Yes
:No

✔

Test
(iii) B. Does any of the information claimed as confidential otherwise appear in any public documents, including (but not limited to)
safety data sheets; advertising or promotional material; professional or trade publications; state, local, or Federal agency files;
or any other media or publications available to the general public? If yes, please explain why the information should be treated
as confidential.

CBI:

Yes
:No

✔

Test
(iii) C. Does any of the information claimed as confidential appear in one or more patents or patent applications? If yes, provide the
associated patent number or patent application number (or numbers) and explain why the information should be
treated as confidential.

CBI:

Yes
:No

✔

Test
(iv) Is the claim of confidentiality intended to last less than 10 years (see TSCA section 14(e)(1)(B))? If yes, please indicate the
number of years (between 1-10 years) or the specific date after which the claim is withdrawn.

CBI:

Yes
:No

✔

Test
(v). Has EPA, another federal agency, or court made any confidentiality determination regarding information associated with
this chemical substance? If yes, please provide the circumstances associated with the prior determination, whether the
information was found to be entitled to confidential treatment, the entity that made the decision, and the date of the
determination.

CBI:

Yes
:No

✔

Test

Substantiation - Chemical Identity Claim
(i)

Is this chemical substance publicly known (including by your competitors) to be in U.S. commerce? If yes, please explain why
the specific chemical identity should still be afforded confidential status (e.g., the chemical substance is publicly known only as
being distributed in commerce for research and development purposes, but no other information about the current commercial
distribution of the chemical substance in the United States is publicly available). If no, please complete the certification
statement:

CBI:

Yes
:No

✔

I certify that on the date referenced I searched the internet for the chemical substance identity (i.e., by both chemical substance
name and CASRN). I did not find a reference to this chemical substance that would indicate that the chemical is being
manufactured or imported by anyone for a commercial purpose in the United States. [provide date].
Test
(ii) Does this specific chemical substance leave the site of manufacture (including import) in any form, e.g., as a product, effluent,
emission? If yes, please explain what measures have been taken to guard against the discovery of its identity.

CBI:

Yes
:No

✔

Test

Page 2

EPA Form Number 9600-034

CBI SUBMISSION

(ii) If the chemical substance leaves the site in a form that is available to the public or your competitors, can the chemical identity
be readily discovered by analysis of the substance (e.g., product, effluent, emission), in light of existing technologies and any
costs, difficulties, or limitations associated with such technologies? Please explain why or why not.

CBI:

Yes
:No

✔

Test
(iv) Would disclosure of the specific chemical identity release confidential process information? If yes, please explain.

CBI:

Yes
:No

✔

Test

Part VII - Certification
I hereby certify to the best of my knowledge and belief that all information entered on this form is complete and accurate. I further certify that, pursuant to 15 U.S.C. § 2613(c), for all claims for
protection of any confidential information made with this submission, all information submitted to substantiate such claims is true and correct, and that it is true and correct that I have:
(i) taken reasonable measures to protect the confidentiality of the information;
(ii) determined that the information is not required to be disclosed or otherwise made available to the public under any other Federal law;
(iii) a reasonable basis to conclude that disclosure of the information is likely to cause substantial harm to the competitive position of the person; and
(iv) a reasonable basis to believe that the information is not readily discoverable through reverse engineering.
Any knowing and willful misrepresentation is subject to criminal penalty pursuant to 18 U.S.C. § 1001.
Signature of authorized official: William Brigman

Date: 2021-08-24

This collection of information is approved by the United States Office of Management and Budget (OMB) under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. (OMB Control No. 2070-0033).
Responses to this collection of information are mandatory for certain persons, as specified at 15 U.S.C. 2601 et. seq. An agency may not conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB control number. The public reporting and recordkeeping burden for this collection of information is estimated to be 137 hours per response.
Send comments on the Agency’s need for this information, the accuracy of the provided burden estimates and any suggested methods for minimizing respondent burden to the Regulatory Support
Division Director, U.S. Environmental Protection Agency (2821T), 1200 Pennsylvania Ave., NW, Washington, D.C. 20460. Include the OMB control number in any correspondence. Do not send the
completed form to this address.

Page 3

EPA Form Number 9600-034


File Typeapplication/pdf
File Modified2021-12-03
File Created2021-08-24

© 2024 OMB.report | Privacy Policy